ROMed2VR

The ROMed2VR project is a pioneering initiative focused on advancing pre-surgical planning for congenital heart defects by combining the power of Computational Fluid Dynamics (CFD) and Virtual Reality (VR). By developing a fast, reliable computational workflow based on open-source CFD and Reduced Order Models (ROM), the project aims to support surgeons in optimizing Modified Blalock-Taussig Shunt procedures with greater precision and confidence.

Launched in November 2024 with a kickoff meeting in Trieste, Italy, ROMed2VR brings together a multidisciplinary consortium of experts. Among the partners is ENGYS, a company specializing in the development of cutting-edge open-source CFD technologies, contributing its expertise to ensure accurate and efficient simulation workflows. The project also includes RBF Morph, known for its innovation in mesh morphing and ROM applications; InSilicoTrials Technologies, a leader in digital health platforms; and the BioCardioLab of Fondazione Toscana Gabriele Monasterio, a prominent cardiovascular research center. Together, these organizations are developing a powerful toolset that leverages simulation and immersive visualization to improve clinical decision-making and patient outcomes.

Over the course of 12 months, ROMed2VR will bridge engineering and medicine, offering a cutting-edge solution that empowers healthcare professionals through science-driven, patient-specific planning.

ROMed2VR is financed by the European Union, and specifically by NextGenerationEU through the iNEST project.